| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ᅟ
|
|
|
2016
|
11 |
6 |
p. 701-704
|
article
|
| 2 |
Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
|
Keating, Gillian M.
|
|
2016
|
11 |
6 |
p. 825-835
|
article
|
| 3 |
Annual Congress of the European Society for Medical Oncology (ESMO): Copenhagen, Denmark; 7–11 October 2016
|
Chopra, Martin
|
|
2016
|
11 |
6 |
p. 705-709
|
article
|
| 4 |
Anti-EGFR Agents: Current Status, Forecasts and Future Directions
|
Kwapiszewski, Radoslaw
|
|
2016
|
11 |
6 |
p. 739-752
|
article
|
| 5 |
Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)
|
Tsuji, Akihito
|
|
2016
|
11 |
6 |
p. 799-806
|
article
|
| 6 |
Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines
|
Wang, Cong
|
|
2016
|
11 |
6 |
p. 771-781
|
article
|
| 7 |
Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines
|
Wysham, Weiya Z.
|
|
2016
|
11 |
6 |
p. 763-769
|
article
|
| 8 |
Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
|
Pinkerneil, Maria
|
|
2016
|
11 |
6 |
p. 783-798
|
article
|
| 9 |
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial
|
Vinik, Aaron
|
|
2016
|
11 |
6 |
p. 815-824
|
article
|
| 10 |
Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors
|
Mita, Monica M.
|
|
2016
|
11 |
6 |
p. 807-814
|
article
|
| 11 |
Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis
|
Li, Xue
|
|
2016
|
11 |
6 |
p. 753-761
|
article
|
| 12 |
Retraction Note to: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8
|
Wang, Ying
|
|
2016
|
11 |
6 |
p. 839
|
article
|
| 13 |
Retraction Note to: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials
|
Liu, Jin
|
|
2016
|
11 |
6 |
p. 837
|
article
|
| 14 |
Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
|
Wang, Juan
|
|
2016
|
11 |
6 |
p. 723-738
|
article
|
| 15 |
Will Testicular Germ Cell Tumors Remain Untargetable?
|
Aoun, Fouad
|
|
2016
|
11 |
6 |
p. 711-721
|
article
|
Journal description